US·Bill·118th Congress

HR 1199

Died in committee

Facilitating Innovative Nuclear Diagnostics Act of 2023

Introduced 2026-04-20Last action 2026-04-20 — Forwarded by Subcommittee to Full Committee by Voice Vote.Committees House Committee on Energy and Commerce, House Committee on Ways and Means
⚫
Died in committee
The 118th Congress ended on 2025-01-03. This bill was in committee when the session adjourned and did not advance to enactment.

Legislative Progress

✓
Introduced
✗
In Committee
3
Passed Chamber
4
Enacted / Signed

Action History

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-02-27 · House floor actions
Introduced in House
2023-02-27 · Library of Congress
Referred to the Subcommittee on Health.
2023-03-10 · House committee actions
Forwarded by Subcommittee to Full Committee by Voice Vote.
2024-05-16 · House committee actions
Subcommittee Consideration and Mark-up Session Held
2024-05-16 · House committee actions

Summary

Facilitating Innovative Nuclear Diagnostics Act of 2023

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Full Bill Text
https://www.congress.gov/bill/118th-congress/hr/1199
View full text →